Clinical Trials in Los Angeles

Showing 14481-14500 of 16,901 trials

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

NCT00003274

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. It is not yet known what preparation of vaccine therapy is most effective for treating melanoma. PURPOSE: Randomized phase II trial to study the effectiveness of tyrosinase/gp100 peptide vaccine in treating patients who have stage II melanoma that can be removed by surgery.

Melanoma (Skin)

University of Southern California48 participantsStarted Mar 1998

Los Angeles, California, United States • Ann Arbor, Michigan, United States

COMPLETEDPhase 2< 1 mile

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

NCT00085189

This pilot phase II trial studies how well giving vaccine therapy works in treating patients with stage IIC-IV melanoma. Vaccines made from melanoma peptides or antigens may help the body build an effective immune response to kill tumor cells

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+14 more

University of Southern California42 participantsStarted May 2004

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

A School Program for Children Exposed to Violence

NCT00260195

This study will develop a program to help school children deal with violence-related trauma.

Stress Disorders, Post-TraumaticDepression

RAND78 participantsStarted Jul 2005

Los Angeles, California, United States

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

A School Program for Children Exposed to Violence

Find Trials by Condition in Los Angeles

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer

Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers

Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma

Cryosurgery in Treating Patients With Soft Tissue Sarcoma

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia